Clinical Trial Update: Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating HuCNS-SC neural stem cells in infants with infantile or late-infantile neuronal ceroid lipofuscinosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Neuronal Ceroid Lipofuscinosis
• Late-infantile Neuronal Ceroid Lipofuscinosis

Drugs mentioned

• HuCNS-SC Cells (HuCNS-SC)

Snippet

Sponsor: StemCells, Inc. | Conditions: Neuronal Ceroid Lipofuscinosis | Phase 1 | Status: COMPLETED